Znani so prejemniki sredstev 2. razpisa Inovacijskega sklada UL
10. novembra 2021 je rektor Univerze v Ljubljani prof. dr. Gregor Majdič v okviru festivala UNI.MINDS razglasil letošnje prejemnike sredstev razpisa Inovacijskega sklada UL.
10. novembra 2021 je rektor Univerze v Ljubljani prof. dr. Gregor Majdič v okviru festivala UNI.MINDS razglasil letošnje prejemnike sredstev razpisa Inovacijskega sklada UL.
Our invention combines two methods of water purification, cavitation and plasma. The advantage over other methods of water purification is mainly in energy efficiency and the fact that no additional chemicals are needed for efficient operation.
Our invention is an alternative technological solution: a new and efficient combination of hydrodynamic cavitation, photochemical and photocatalytic processes. It is a combination of green oxidation processes that do not require the addition of external oxidants, and thus do not contribute to the formation of secondary pollutants in the treated sample.
V sredo, 8. septembra 2021, ob 14. uri se nam pridružite na spletnem dogodku, kjer se bomo pogovarjali z direktorjem TECOS-a dr. Alešem Hančičem. Govorili bomo o poti, ki jo izdelek naredi od začetne ideje preko prototipa pa vse do redne proizvodnje.
Our specification refers to novel conjugated compounds that function as immunostimulants and are useful for the treatment of viral, bacterial, fungal and protozoal infections, tumours or cancers and other immunological diseases. Additionally, the conjugated compounds of the invention can be used as vaccine adjuvants.
Najboljše ideje se porodijo v najboljši družbi. Zato bodo v Pisarni za prenos znanja Univerze v Ljubljani še pred koncem prijav na prvi HUD razpis izvedli spletno delavnico z mednarodno priznano profesorico in predavateljico izr. prof. dr. Anjo Svetina Nabergoj. Delavnica se bo odvila v ponedeljek, 23. avgusta, ob 15. uri prek platforme Zoom.
Izšla je angleška različica Vodnika po prenosu znanja na Univerzi v Ljubljani, ki so ga za raziskovalce pripravili v Pisarni za prenos znanja UL.
Bacillus subtilis strain PS-216 has been shown to have strong inhibitory activity against enteropathogenic and/or foodborne pathogenic bacteria, such as Campylobacter jejuni. Particularly, our innovative product uses the Bacillus subtilis strain PS-216 for the preparation of food compositions and probiotic compositions.
A significant advantage of nitroxoline over other candidate drugs for the treatment of covid-19 (repurposing drugs – amantadine, teicoplanin) is that the mechanism of action on the target has been extensively investigated. Our process can additionally generate a variety of compounds with improved antiviral activity.